The goal of this clinical trial is to evaluate the feasibility of intervention implementation in two clinics in rural KY, and its preliminary efficacy with regards to increasing vaccine confidence in a sample of vaccine hesitant parents. Hypothesis: Parents will report increased vaccine confidence scores post-intervention. Data from this study will provide preliminary data for a larger scale evaluation of the intervention. Participants will be asked to complete surveys, view a web-based intervention and then visit with their child's healthcare provider.
Participants will be asked to complete a brief screening assessment to establish their eligibility for participation. Eligible participants will be asked to complete a consent form and be directed to the pre-test survey. Upon completion of the survey, the participants will be directed to the tailored intervention content, including the Parents' Stories videos. This step will be completed prior to interaction with the provider. During the provider-patient visit, the provider will deliver the elaborated prompt portion of the intervention to participating mothers. Mothers will receive a link to the post-test survey two weeks following their appointment.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
PREVENTION
Masking
NONE
Enrollment
58
A web application for vaccine-hesitant parents and their teens with brief, 90-second narrative videos and tailored, motivational content
A component for providers that suggests elaborated prompts to be used with parents that align with the content of the web application, are tailored to parent concerns, and are motivational in nature
University of Kentucky
Lexington, Kentucky, United States
Change in HPV Vaccine Hesitancy Scale score
9-item scale from Strongly Disagree (1) to Strongly Agree (5); scores range from 1-5, with higher scores indicating greater hesitancy
Time frame: From pretest to posttest (up to two weeks)
Change Human Papillomavirus Knowledge Questionnaire score
13-item scale with True / False / I don't know response options; scores range from 0-13 with higher scores indicating greater vaccine knowledge
Time frame: From pretest to posttest (up to two weeks)
Change in intent to discuss HPV vaccine with provider
Answers include Very likely; Somewhat likely; Not too likely; Not likely at all; Not sure / do not know
Time frame: From pretest to posttest (up to two weeks)
Change in HPV vaccine intent
1 item adapted from NIS-TEEN survey. Answers include very likely; somewhat likely; not too likely; not likely at all; not sure / do not know
Time frame: From pretest to posttest (up to two weeks)
Change in self-reported HPV vaccination and related provider recommendations
4 items adapted from the NIS-TEEN survey.
Time frame: from screening to posttest (up to two weeks)
Change in Reasons Not to Vaccinate score
16 items adapted from NIS-TEEN survey; higher score indicates more obstacles to vaccination
Time frame: Pretest only
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.